logo
logo
Sign in

Pendred Syndrome Market Shows Strong Growth with Leading Players | , Sensorion, Advanced Bionics AG, MED-EL Medical Electronics, Cochlear Ltd, Sonova, GAES, Demant A/S.

avatar
Market newstrends
Pendred Syndrome Market Shows Strong Growth with Leading Players | , Sensorion, Advanced Bionics AG, MED-EL Medical Electronics, Cochlear Ltd, Sonova, GAES, Demant A/S.

Pendred Syndrome Market is a rare inherited genetic disorder caused by caused by mutations in a gene called SLC26A4 (formerly known as the PDS gene) on chromosome 7. It is characterized by bilateral sensorineural hearing loss and euthyroid goiter. Basically, this syndrome affects the body’s ability to make protein called pendrin, which is essential for normal function of inner ear and thyroid. The Pendred syndrome is given a named after physician Vaughan Pendred, who first discovered the people with the disorder

Global Pendred syndrome Market is expected to grow at a substantial CAGR in the forecast period of 2019-2026. Emgerence of drugs used to treat risk associated with Pendred syndrome such as goiter and high demand of disease specific novel therapies are the key factors that fueling the market growth

 Get Sample Report at :

https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-pendred-syndrome-market

Competitive Analysis: Global Pendred Syndrome Market

Few of the major competitors currently working in Global Pendred Syndrome Market are Nobelpharma Co., Ltd, Sensorion, Advanced Bionics AG, MED-EL Medical Electronics, Cochlear Ltd, Sonova, GAES, Demant A/S, Nurotron Biotechnology Co. Ltd, GN Store Nord A/S, Amplifon, Audina Hearing Instruments, Inc, Elkon Pvt. Ltd, Rion Co. , Ltd, Starkey and others.

 Key Pointers Covered in the Global Pendred Syndrome Market Trends and Forecast to 2026

  • Global   Pendred Syndrome Market New Sales Volumes
  • Global   Pendred Syndrome  Market Replacement Sales Volumes
  • Global   Pendred Syndrome Market Installed Base
  • Global   Pendred Syndrome Market By Brands
  • Global   Pendred Syndrome Market Size
  • Global   Pendred Syndrome  Market Procedure Volumes
  • Global   Pendred Syndrome Market Product Price Analysis
  • Global   Pendred Syndrome Market Healthcare Outcomes
  • Global   Pendred Syndrome Market Cost of Care Analysis
  • Global   Pendred Syndrome Market Regulatory Framework and Changes
  • Global   Pendred Syndrome Market Prices and Reimbursement Analysis
  • Global   Pendred Syndrome Market Shares in Different Regions
  • Recent Developments for Global   Pendred Syndrome Market Competitors
  • Global   Pendred Syndrome Market Upcoming Applications
  • Global   Pendred Syndrome Market Innovators Study

Get Detailed TOC:

https://www.databridgemarketresearch.com/toc/?dbmr=global-pendred-syndrome-market

Key Developments in the Market:

  • In July 2019, Sensorion received the Investigational New Drug (IND) approval from the FDA to proceed with arazasetron besylate (formally known as SENS-401) for the treatment of sudden sensorineural hearing loss. This drug is also received an Orphan Drug designation in the Europe. With this IND approval, company can initial trials on human subject and if trial successful, SENS-401 could be a safe and effective treatment options for underserved patient population.
  • In July 2019, Nobelpharma Co., Ltd in collaboration with Keio University is developing Rapalimus (formally known as NPC-12), for the treatment of Pendred syndrome. Rapalimus is in phase I/IIa clinical trial. If trial successful, it will be first ever approved drug for the treatment of Pendred syndrome.

Market Drivers

  • Family history of Pendred syndrome is driving the growth of the market
  • Advancement in cochlear implantation and hearing kits can improve the hearing is enhancing the market growth
  • Huge financial support to the researchers for developing novel intervention is boosting the market growth
  • High demand of disease specific novel treatment can also act as a market driver

Market Restraints

  • Limited operating revenue opportunities for research and development of targeted therapies by many pharmaceuticals is acting as a challenging factor for the growth of this market
  • Low healthcare budget in some developing countries is hamper the market growth
  • Unaffordability and inaccessibility of cochlear implant to many underserve population can act as a restricting factor in the growth of this market

 Inquire Before Buying:

https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-pendred-syndrome-market

Key insights in the report:

  • Complete and distinct analysis of the market drivers and restraints
  • Key Market players involved in this industry
  • Detailed analysis of the Market Segmentation
  • Competitive analysis of the key players involved

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market.

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: [email protected]

Browse Related Report Here:

Metastatic Melanoma Market

Schistosomiasis Diseases Market

collect
0
avatar
Market newstrends
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more